Dengue Fever: Causes, Complications, and Vaccine Strategies

Table 2

Dengue vaccine candidates currently in different phases of clinical trials.

Type of vaccine	Developer	Phase
Chimeric yellow virus dengue vaccine (CYD)	Sanofi Pasteur	Licensed
Intertypic chimera-DENVax	CDC-Inviragen/Takeda	III
Targeted mutagenesis based LAV-TetraVax-DV	NIH	III
Cell culture based LAV	WRAIR-GSK	II
Purified inactivated vaccine-TDENV-PIV	WRAIR-GSK	I
Recombinant subunit vaccine-V180	Hawaii Biotech, Merck and Co.	I
DNA vaccine expressing prM and E protein	Naval Medical Research Centre, WRAIR	I